Rebecca Taub, Chief Medical Officer, EVP R&D at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 73,526 shares at $287.46 ($21.1M) on 2018-06-11, disclosed to the SEC on 2018-06-12.
Scheduled sale ($21.1M) by Chief Medical Officer, EVP R&D.
Something here stands out, but not much.
| Filing → |
| MDGL | SELL | 2026-01-20 | $1.1M | — | Filing → |
| MDGL | SELL | 2026-01-13 | $18.9M | — | Filing → |
| MDGL | SELL | 2026-01-13 | $242K | — | Filing → |